Form 483

Binder Biomedical Inc Form 483, 2011-02-04

FDA issued a Form 483 to Binder Biomedical Inc on 2011-02-04 with 5 public-safe observations.

483· Form 483 issued5 observations

Binder Biomedical Inc · Miami, United States · Issued February 4, 2011

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

4 Feb 2011
21 CFR 820.22

Quality Audits - defined intervals

Cited by Richard K Vogel

4 Feb 2011
21 CFR 820.50(a)

Evaluation of suppliers, contractors, etc., requirements

Cited by Richard K Vogel

4 Feb 2011
21 CFR 820.72(a)

Calibration, Inspection, etc. Procedures Lack of or Inadequ

Cited by Richard K Vogel

4 Feb 2011
21 CFR 820.100(a)

Lack of or inadequate procedures

Cited by Richard K Vogel

4 Feb 2011
21 CFR 820.184

DHR - not or inadequately maintained

Cited by Richard K Vogel

Inspected site

BBBinder Biomedical IncMiami, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.100(a)Cited across public-safe Form 483 observations1x
21 CFR 820.184Cited across public-safe Form 483 observations1x
21 CFR 820.22Cited across public-safe Form 483 observations1x
21 CFR 820.50(a)Cited across public-safe Form 483 observations1x
21 CFR 820.72(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere